Understanding and Dealing the SARS-CoV-2 Infection: An Updated Concise Review

Viral infection has made the world to pass through most critical time of current century. In December 2019, Wuhan city China faced a novel etiological viral agent with atypical secondary pneumonia. The unique virus was severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that caused coronavirus disease 2019 (COVID-19) pandemic. According worldometer data, as 24, 2020, lost more than 1.74 million lives and infected 79.3 people coronavirus-2. As there is no approved drug combat or vaccine against virus, continuously triumphed over medical system. epidemiological analysis showed geriatric patients are generally susceptible infection, pediatric exhibited milder complications. clinical characteristics COVID-19 displayed frequent symptoms dry cough, fever, dyspnea, sputum production. Herd immunity tested strategy could moderate transmission in developing countries. this study, authors abridged outcomes, features, pathophysiology SARS-CoV-2 infection. article also focused on development, herd immunity, promising repurposed therapeutics for treatment their trial updates.
 Bangladesh Pharmaceutical Journal 24(1): 61-75, 2021